Propane-1,3-dione derivative

Details Propane-1,3-dione derivative Propane-1,3-dione derivative

2005-11-01

2005-11-01

Rao, Deepak (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S256000, C514S303000, C514S314000, C514S322000, C514S333000, C514S338000, C514S365000, C514S367000, C514S394000, C544S242000, C544S333000, C544S336000, C544S405000, C546S118000, C546S174000, C546S199000, C546S256000, C546S273400, C548S180000, C548S181000, C548S304400, C548S304700, C548S305400, C548S306100, C548S310400

Reexamination Certificate

active

06960591

ABSTRACT:
Provided is a pharmaceutical composition containing a propane-1,3-dione derivative as the active ingredient, particularly a GnRH receptor antagonist. Also, provided is a propane-1,3-dione derivative having a GnRH antagonistic effect.

REFERENCES:
patent: 4062686 (1977-12-01), Van Allan et al.
patent: 4119466 (1978-10-01), Van Allan et al.
patent: 5202221 (1993-04-01), Imai et al.
patent: 5616537 (1997-04-01), Yokota et al.
patent: 5770544 (1998-06-01), Yokota et al.
patent: 5817819 (1998-10-01), Furuya et al.
patent: 0 135 348 (1985-03-01), None
patent: 0 332 044 (1989-09-01), None
patent: 0 368 327 (1990-05-01), None
patent: 368327 (1990-05-01), None
patent: 0 631 177 (1994-12-01), None
patent: 2000-95767 (2000-04-01), None
patent: WO 94/01415 (1994-01-01), None
patent: WO 95/28405 (1995-10-01), None
patent: WO 99/52888 (1999-10-01), None
patent: WO 02/102401 (2002-12-01), None
Simone, Oncology: Introduction, Cecil Textbook of Medicine, 20thEdition, vol. 1, pp. 1004-1010, 1996.
Huirne et al., PubMed Abstract (Lancet 358(9295):1793-803), Nov. 2001.
Holik, Miroslav, et al., “Spectroscopic investigation of β-di-carbonl compounds. Part III. Proton-NMR study of transfer of substituent effects in 2-dibenzoylmethylene-3-ethylbenzo-thiazolines and—selezazolines”; Collect. Czech. Chem. Commun. (1978), 43(3), 739-45.
Junko Ishida et al., “Antitumor Agents. Part 214:†Synthesis and Evaluation of Curcumin Analogues as Cytotoxic Agents” Bioorganic & Medicinal Chemistry 10 (2002) 3481-3487.
I.B. Dzvinchuk et al., “Formation of Unsymmetrical 2-(Diacylmethylene)-2,3-Dihydro-1H-Benzimidazoles During Acidolysis of 1-Benzoyl2-(β-Benzoyloxy-β-Phenylvinyl)-1H-Benzimidazole”, vol. 37, Chemistry of Heterocyclic Compounds, No. 5 (2001), pp. 554-559.
Jaro Komenda et al., Electrochemical Behavior and ESR Spectra of Nitro Substituted Mono-to and Debenzoylmethylenebenzthiazolines and Selenazolies, Collect. Czech. Chem. Commun. (1979), vol. 44(5), pp. 1540-51.
Miroslav Holik et al., H-NMR Study of Transfer of Substituent Effects in 2-Dibenzoylmethylene 3-Ethylbenzothiazolines and -Selenazolines, Collect. Czech. Chem. Commun. (1978), vol. 43(3), pp. 739-745.
A. Mistr et al., Organische Lichtempfindliche Stoffe V. Aclmethylenderivate Heterocyclischer Stickstoffhaltiger Basen ALS Sensibilisatoren Lichtempfindlicher Polymerer, Collect. Czech. Chem. Commun. (1973), vol. 38(12), pp. 3616-3622.
A. Mistr et al., Organische Lichtempfindliche Stoffee II. Benzoylmethylenderivate Heretocyclischer Stickstoffhaltiger Basen ALS Sensibilisatoren Fur Lichtempfinliche Polymere, Collect. Czech. Commun. (1971), vol. 36(1), pp. 150-163.
G.I. Gaeva and K.S. Liadikov, Zh. Nauch. Prikl. Fotogr. Kinematogr. (1971) vol. 16(4), pp. 282-288.

Affiliated with

Also associated with

Rating

Propane-1,3-dione derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Propane-1,3-dione derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Propane-1,3-dione derivative will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3471229